Are intravitreal anti-VEGF antibodies safe?

Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):1-2. doi: 10.1080/09273940701246314.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Aptamers, Nucleotide / administration & dosage
  • Aptamers, Nucleotide / adverse effects*
  • Exudates and Transudates
  • Humans
  • Injections
  • Macular Degeneration / complications
  • Macular Degeneration / drug therapy*
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / immunology*
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Aptamers, Nucleotide
  • Vascular Endothelial Growth Factor A
  • pegaptanib